论文部分内容阅读
目的探讨CA199、CA242对胰腺癌的诊断价值。方法选取2009年5月至2010年5月来我院就诊的70例胰腺癌的患者,作为恶性胰腺癌组;良性胰腺癌组30例;正常组40例。检测三组患者的CA199、CA242水平。结果三组患者血清中CA199、CA242水平结果显示,恶性胰腺癌组的CA199、CA242水平远远高于其他两组,良性胰腺癌组高于正常组。三组比较差异具有统计学意义(P<0.05)。结论检测血清中的CA199、水平,对胰腺癌的诊断具有重要的作用,它可以作为早期诊断胰腺癌的工具,提高了胰腺癌的诊断和鉴别诊断的疗效。
Objective To investigate the diagnostic value of CA199 and CA242 in pancreatic cancer. Methods Seventy patients with pancreatic cancer who came to our hospital from May 2009 to May 2010 were selected as malignant pancreatic cancer group, 30 as benign pancreatic cancer group and 40 as normal group. Three groups of patients were tested CA199, CA242 levels. Results The serum levels of CA199 and CA242 in three groups of patients showed that the levels of CA199 and CA242 in patients with malignant pancreatic cancer were much higher than those in the other two groups, and were higher in benign pancreatic cancer group than in normal group. The difference between the three groups was statistically significant (P <0.05). Conclusion Detection of serum CA199 level has an important role in the diagnosis of pancreatic cancer. It can be used as a tool to diagnose pancreatic cancer in the early stage and improve the diagnosis and differential diagnosis of pancreatic cancer.